Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections.

Biotechnology

Education

Excision BioTherapeutics

Excision BioTherapeutics' headquarters in San Francisco, CA, United States

Daniel Dornbusch

TJ Cradick

Franz Gerner

William Kennedy

Christine Silverstein

Sara Turken

Toni Cathomen

Joseph Berger

Kenneth L. Tyler

John Baxter

David Clifford

Timothy M. Block

Vasudev Bailey

Keith Jerome

Nicole Paulk

Mark Pruzanski

Joseph Bondy-Denomy

Michael Marks

Paul Sekhri

David Thomas

Ashok Krishnamurthi

Sandy Zweifach

Mike Walker

Jeff Kindler

Lisa Danzig

Annalisa Jenkins

Bill Carson

The Corporate Governance and Strategy team at Excision BioTherapeutics focuses on establishing robust governance frameworks and strategic initiatives to advance the company's mission of developing gene-editing therapeutics. This multidisciplinary team, comprising legal, scientific, and business experts, ensures compliance with regulatory standards while also advising on research and development strategies, operational decisions, and corporate partnerships to drive innovation and enhance the organization's competitive position in the biopharmaceutical landscape.

Corporate Governance and Strategy

The Scientific Research and Development team at Excision BioTherapeutics is dedicated to advancing gene-editing technologies aimed at creating innovative therapeutics for viral infections. This multidisciplinary team conducts cutting-edge research, develops and validates genome editing techniques, ensures quality assurance, and utilizes bioinformatics to analyze data, ultimately working to translate scientific discoveries into effective treatments for life-threatening diseases.

Scientific Research and Development

The Leadership Team at Excision BioTherapeutics is responsible for setting the strategic direction and vision of the company, guiding its mission to develop innovative gene-editing therapeutics. This team, comprised of the CEO, CFO, CTO, and Chief Scientific Officer, works collaboratively to ensure operational excellence, drive scientific advancements, and secure funding while fostering partnerships that enhance the company’s capabilities in addressing life-threatening viral diseases.

Leadership Team

Excision BioTherapeutics

Org chart

Board & advisors

Teams

Corporate Governance and Strategy

Scientific Research and Development

Leadership Team

Offices

Excision BioTherapeutics

Org chart

Board & advisors

Teams

Corporate Governance and Strategy

Scientific Research and Development

Leadership Team

Offices

Related companies